Literature DB >> 20020578

Adiposity is associated with endothelial activation in healthy 2-3 year-old children.

Cecilia Castro1, Russell P Tracy, Richard J Deckelbaum, Charles E Basch, Steven Shea.   

Abstract

Adiposity is associated with C-reactive protein level in healthy 2-3 year-old children and with other markers of endothelial activation in adults, but data are lacking in very young children. Data from 491 healthy Hispanic children were analyzed. Mean age was 2.7 years (SD 0.5, range 2-3 years); mean body mass index (BMI) was 17.2 kg/m2 (SD 1.9) among boys and 17.1 kg/m2 (SD 2.1) among girls. E-selectin level was associated with BMI (R = 0.11; p < 0.02), ponderal index (p < 0.02), waist circumference (p = 0.02), fasting insulin (p < 0.02), and insulin resistance (p < or = 0.05); these associations remained significant after adjustment for age, sex and fasting glucose. sVCAM was also associated with BMI (R = 0.12; p < 0.05). These observations indicate that adiposity is associated with inflammation and endothelial activation in very early childhood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20020578      PMCID: PMC3603688          DOI: 10.1515/jpem.2009.22.10.905

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  46 in total

1.  Prospective analysis of the insulin-resistance syndrome (syndrome X).

Authors:  S M Haffner; R A Valdez; H P Hazuda; B D Mitchell; P A Morales; M P Stern
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

2.  Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

Authors:  K Pyöräla
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

Review 3.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

4.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.

Authors:  Andreas Festa; Anthony J G Hanley; Russell P Tracy; Ralph D'Agostino; Steven M Haffner
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

6.  Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors.

Authors:  Maro R I Williams; Tye Dawood; Shanhong Ling; Aozhi Dai; Robert Lew; Kathy Myles; John W Funder; Krishnankutty Sudhir; Paul A Komesaroff
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

7.  Impact of physical training and detraining on endothelium-dependent vasodilation in patients with recent acute myocardial infarction.

Authors:  M Vona; A Rossi; P Capodaglio; S Rizzo; P Servi; M De Marchi; F Cobelli
Journal:  Am Heart J       Date:  2004-06       Impact factor: 4.749

8.  Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia.

Authors:  M J Sotsky; S Shilo; H Shamoon
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

9.  Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; S J Kittner; M G Bond; S K Wolfson; W Bommer; T R Price; J M Gardin; P J Savage
Journal:  Stroke       Date:  1992-12       Impact factor: 7.914

Review 10.  Insulin resistance, inflammation, and the prediabetic state.

Authors:  Steven M Haffner
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

View more
  4 in total

1.  Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

Authors:  T I Miller; W Borkowsky; L A DiMeglio; L Dooley; M E Geffner; R Hazra; E J McFarland; A J Mendez; K Patel; G K Siberry; R B Van Dyke; C J Worrell; D L Jacobson; William Shearer; Norma Cooper; Lynette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Doyle Patton; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Ram Yogev; Kathleen Malee; Scott Hunter; Eric Cagwin; Andrew Wiznia; Marlene Burey; Molly Nozyce; Janet Chen; Elizabeth Gobs; Mitzie Grant; Katherine Knapp; Kim Allison; Patricia Garvie; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Cheryl Borne; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Emily Barr; Carrie Chambers; Douglas Watson; Nicole Messenger; Rose Belanger; Arry Dieudonne; Linda Bettica; Susan Adubato; Gwendolyn Scott; Lisa Himic; Elizabeth Willen
Journal:  HIV Med       Date:  2011-12-04       Impact factor: 3.180

2.  Objectively measured sedentary time, physical activity and markers of body fat in preschool children.

Authors:  Vanesa España-Romero; Jonathan A Mitchell; Marsha Dowda; Jennifer R O'Neill; Russell R Pate
Journal:  Pediatr Exerc Sci       Date:  2013-02       Impact factor: 2.333

3.  Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours.

Authors:  M Constantine Samaan; Lehana Thabane; Sarah Burrow; Rejane F Dillenburg; Katrin Scheinemann
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

4.  Recruitment feasibility to a cohort study of endocrine and metabolic health among survivors of childhood brain tumours: a report from the Canadian study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE).

Authors:  M Constantine Samaan; Katrin Scheinemann; Sarah Burrow; Rejane F Dillenburg; Ronald D Barr; Kuan-Wen Wang; Marlie Valencia; Lehana Thabane
Journal:  BMJ Open       Date:  2014-06-26       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.